Navigating the expanded access investigational new drug protocol for tecovirimat: lessons learned from a public–private hospital partnership during the 2022 NYC mpox outbreak

Author:

Mgbako OfoleORCID,Chan Justin,Pitts Robert A.,DiLorenzo Madeline A.ORCID,Knutsen Dorothy,Mazo Dana

Abstract

Abstract During the 2022 mpox outbreak, tecovirimat was accessed through an expanded access investigational new drug (EA-IND) protocol. We leveraged a unique public/private hospital partnership in New York City to create a novel infrastructure to navigate the EA-IND’s regulatory requirements and rapidly provide tecovirimat to patients.

Publisher

Cambridge University Press (CUP)

Subject

Infectious Diseases,Microbiology (medical),Epidemiology

Reference8 articles.

1. Epidemiologic and Clinical Characteristics of Monkeypox Cases — United States, May 17–July 22, 2022

2. 4. United States Department of Health and Human Services. Administration for Strategic Preparedness and Response. ASPR Awards $21 Million to Health Facilities to Enhance Nation’s Preparedness for Special Pathogens. October 24, 2022. https://aspr.hhs.gov/newsroom/Pages/RESPTC-Prep-Award-24Oct2022.aspx. Accessed March 27, 2023.

3. 5. Mgbako, O , Ditullio, D , PaganPirallo, P , et al. Outcomes of a telehealth visit model to deliver tecovirimat. Conference on Retroviruses and Opportunistic Infections. Abstract 1102. Seattle, Washington. February 2023.

4. 1. United States Centers for Disease Control and Prevention. Mpox. 2022 U.S. Map and Case Count. https://www.cdc.gov/poxvirus/mpox/response/2022/us-map.html. Accessed March 13, 2023.

5. 2. New York City Department of Health. Mpox 2022 Summary: Cases. https://www.nyc.gov/assets/doh/downloads/pdf/monkeypox/mpox-response-data-summary.pdf. Accessed March 13, 2023.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3